SHORT PAPER
Selectively Protected (2S)-1,2,4-Triaminobutane Derivatives
2283
(2S)-N4-Benzyloxycarbonyl-N1,N2-di-tert-butoxycarbonyl-
1,2,4-triaminobutane (5)
Acknowledgment
(2S)-N4-Benzyloxycarbonyl-1,2,4-triaminobutane (4, 1.55 g, 6.5
mmol) was dissolved in MeOH (30 mL) and di-tert-butyldicarbon-
ate (2.85 g, 13.1 mmol) was added, followed by Et3N (1.8 mL, 13.1
mmol). The reaction mixture was stirred for 24 h at r.t. The volatiles
were evaporated under reduced pressure and the residue was dis-
solved in EtOAc (100 mL) and washed with 1 M KHSO4 (3 × 30
mL). The organic phase was dried (MgSO4) and evaporated under
reduced pressure yielding a white precipitate. The product was pu-
rified by column chromatography (silica gel, EtOAc–petroleum
ether, 1:1,5) and crystallized from EtOAc–hexane. Yield: 1.99 g
(70%); mp 118–120 °C (Lit.10 mp 122–123 °C); [a]D24 –23.9 (c = 2,
EtOH) {Lit.10 [a]D23 –23.8, (c = 2, EtOH)}.
The authors are indebted to Dr Zgoda Chemical Research Consul-
ting & Production and the Faculty of Chemistry, Gdaꢀsk University
of Technology for financial support.
References
(1) Sundberg, M. W. J. Med. Chem. 1974, 17, 1304.
(2) Yeh, S. M.; Sherman, D. G.; Meares, C. F. Anal. Biochem.
1979, 100, 152.
(3) Kung, H. F.; Guo, Y.-Z.; Yu, C.-C.; Billings, J.;
Subramanyam, V.; Calabrese, J. C. J. Med. Chem. 1989, 32,
433.
1H NMR (500 MHz, CDCl3): d = 1.40 [s, 9 H, (CH3)3C], 1.42 [s, 9
H, (CH3)3C] 1.65–1.74 (m, 2 H, CHCH2), 2.95–3.04 (m, 1 H,
CH2CH2), 3.08–3.27 (m, 2 H, CH2CH), 3.44–3.54 (m, 1 H,
CH2CH2), 3.63–3.72 (m, 1 H, CH2CH), 4.76–4.85 (br s, 1 H, NH),
4.96–5.03 (br s, 1 H, NH), 5.1 (AB system, J1 = 12.2 Hz, J2 = 23.4
Hz, 2 H, CH2Ph), 5.63–6.71 (br s, 1 H, NH), 7.28–7.38 (m, 5 H,
C6H5).
(4) Gustavson, L. M.; Rao, T. N.; Jones, D. S.; Fritzberg, A. R.;
Srinivasan, A. Tetrahedron Lett. 1991, 32, 5485.
(5) Cox, J. P. L.; Craig, A. S.; Helps, I. M.; Jankowski, K. J.;
Parker, D.; Eaton, M. A. W.; Millican, A. T.; Millar, K.;
Beeley, N. R. A.; Boyce, B. A. J. Chem. Soc., Perkin Trans.
1 1990, 2567.
(6) Dunn, P. J.; Haner, R.; Rapoport, H. J. Org. Chem. 1990, 55,
5017.
(7) Hsu, F.-L.; Hamada, A.; Booher, M. E.; Fuder, H.; Patil, P.
N.; Miller, D. D. J. Med. Chem. 1980, 23, 1232.
(8) Miller, D. D.; Hsu, F.-L.; Ruffolo, R. R.; Patil, P. N. J. Med.
Chem. 1976, 19, 1382.
13C NMR (200 MHz, MeOD): d = 29.1, 33.9, 39.1, 45.7, 50.3, 67.7,
80.4, 129.1, 129.2, 129.7, 138.7, 158.7, 158.9, 159.0.
Anal. Calcd for C22H35N3O6: C, 60.39; H, 8.06; N, 9.60. Found: C,
60.24; H, 8.00; N, 9.71.
(9) Altman, J.; Ben-Ishai, D. Tetrahedron: Asymmetry 1993, 4,
91.
(10) Altman, J.; Ben-Ishai, D.; Beck, W. Tetrahedron:
Asymmetry 1994, 5, 887.
(11) Altman, J.; Beck, W. Tetrahedron 1995, 51, 13309.
(12) Schuhmann, E.; Altman, J.; Karaghiosoff, K.; Beck, W.
Inorg. Chem. 1995, 34, 2316.
(13) Kokotos, G.; Markidis, T.; Constantinou-Kokotou, V.
Synthesis 1996, 1223.
(14) Adamson, D. W. J. Chem. Soc. 1939, 1564.
(15) Hatano, M.; Yoneyama, M. J. Am. Chem. Soc. 1970, 92,
1392.
(16) Vogler, K.; Lanz, P. Helv. Chim. Acta 1960, 43, 270.
(17) Fridecky, M. J.; McGregor, W. H. J. Med. Chem. 1966, 9,
255.
(18) Borthwick, A. D.; Angier, S. J.; Crame, A. J.; Exall, A. M.;
Haley, T. M.; Hart, G. J.; Mason, A. M.; Pennell, A. M. K.;
Weingarten, G. G. J. Med. Chem. 2000, 43, 4452.
(19) Kornet, M. J.; Thio, P. A.; Tan, S. I. J. Org. Chem. 1968, 33,
3637.
(20) Russ, P. L.; Caress, E. A. J. Org. Chem. 1976, 41, 149.
(21) Northrop, R. C.; Russ, P. L. J. Org. Chem. 1977, 42, 4148.
(22) Lane, C. F. Chem. Rev. 1976, 76, 773.
(23) Curran, W. V.; Angier, R. B. J. Org. Chem. 1966, 31, 3867.
(24) Sugano, Y.; Katzenellenbogen, J. A. Bioorg. Med. Chem.
Lett. 1996, 6, 361.
(2S)-N1,N2-Di-tert-butoxycarbonyl-1,2,4-triaminobutane (6)
(2S)-N4-Benzyloxycarbonyl-N1,N2-di-tert-butoxycarbonyl-1,2,4-
triaminobutane (5, 1.70 g, 3.89 mmol) was dissolved in MeOH (40
mL) and AcOH (0.8 mL) was added. The solution was hydrogenat-
ed for 5 h (5% Pd/C). When the reaction was finished, the catalyst
was filtered and the volatiles were evaporated under reduced pres-
sure. The residue was dissolved in 1 M KHSO4 (40 mL) and washed
with Et2O (20 mL). The water phase was saturated with NaCl, alka-
lized with 1 M NaOH and extracted with Et2O (4 × 40 mL). The
ethereal phase was dried (MgSO4) and evaporated under reduced
pressure yielding a white solid product (1.12 g, 95%); mp 75–77 °C
(Lit.10 mp 78–80 °C). The product was also turned into acetate by
dissolving in Et2O and adding appropriate equivalent of AcOH. The
(2S)-N1,N2-di-tert-butoxycarbonyl-1,2,4-triaminobutane
acetate
was precipitated as a white solid; mp 130–131 °C; [a]D24 –7.2 (c =
2, EtOH).
1H NMR (500 MHz, CDCl3): d = 1.40 [s, 9 H, (CH3)3C], 1.43 [s, 9
H, (CH3)3C], 1.52–1.58 (m, 1 H, CHCH2), 1.81–1.90 (m, 1 H,
CHCH2), 2.00 (s, 3 H, CH3COO–), 2.82–2.88 (m, 1 H, CH2CH2),
2.95–3.05 (m, 1 H, CH2CH2), 3.15–3.30 (m, 2 H, CH2CH), 3.65–
3.78 (m, 1 H, CH2CH), 4.95–5.20 (br s, 4 H, NH), 5.43–5.48 (br s,
1 H, NH).
13C NMR (200 MHz, MeOD): d = 24.4, 29.0, 32.3, 38.3, 45.3, 49.3,
80.6, 80.8, 159.0, 180.4.
(25) Harada, H.; Morie, T.; Suzuki, T.; Yoshida, T.; Kato, S.
Tetrahedron 1998, 54, 10671.
Anal. Calcd for C16H33N3O6: C, 52.87; H, 9.15; N, 11.56. Found: C,
52.90; H, 9.05; N, 11.48.
Synthesis 2005, No. 14, 2281–2283 © Thieme Stuttgart · New York